VitaNova Life Sciences Corporation Stock Price, News & Analysis
Company Description
VitaNova Life Sciences Corporation (YJGJD) is a publicly traded medical distribution company in the Healthcare sector. The company has a market capitalization of $40.3M.
On a trailing twelve-month basis, VitaNova Life Sciences Corporation reported revenue of $2.7M with net income of $851K and diluted earnings per share of $0.03. The company operates at a net profit margin of 32.0%.
This page provides a comprehensive overview of YJGJD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
YJGJD Rankings
Latest News
SEC Filings
VitaNova Life Sciences Corporation has filed 3 recent SEC filings, including 2 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on March 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all YJGJD SEC filings →
Financial Highlights
VitaNova Life Sciences Corporation generated $2.7M in revenue over the trailing twelve months, retaining a 59.2% gross margin, operating income reached $1.2M (45.4% operating margin), and net income was $851K, reflecting a 32.0% net profit margin. Diluted earnings per share stood at $0.03. The company generated $193K in operating cash flow. With a current ratio of 5.90, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
YJGJD Company Profile & Sector Positioning
VitaNova Life Sciences Corporation (YJGJD) operates in the Medical Distribution industry within the broader Healthcare sector.